title: The kidney in systemic disease: Part II--Autoimmune and vascular disorders.
abstract: The long-term outlook for the pediatric patient with lupus nephritis has improved dramatically over the past several decades. In 1968, Meislin and Rothfield compared childhood with adult SLE and found the prognosis to be worse when disease onset was at the age of 15 years or younger. Children with renal disease had only a 42% 5-year survival rate vs. an 82% survival rate in adults. Caeiro et al. found the 10-year survival rate in childhood to be only 48%. However, more recent data have demonstrated comparable results for patients of all ages. Ten-year patient survival rates have improved to 69% to 85% as a result of better immunosuppressive therapy, more effective antibiotics, and improved control of hypertension. Despite this overall improvement, severe renal disease continues to complicate the course of 20% to 35% of patients with SLE originating in childhood and demands further investigation of newer therapeutic measures.
authors.affiliation: University of Missouri, Kansas City School of Medicine.
authors.forename: U
authors.initials: U
authors.lastname: Alon
authors.forename: B A
authors.initials: BA
authors.lastname: Warady
authors.forename: S
authors.initials: S
authors.lastname: Hellerstein
mesh_terms: D001327:Autoimmune Diseases / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D002648:Child; D005922:Glomerulonephritis, IGA / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D011695:IgA Vasculitis / Q000175:diagnosis; D007674:Kidney Diseases / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D008181:Lupus Nephritis / Q000175:diagnosis / Q000628:therapy; D014657:Vasculitis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy